US 10323061
Heteroaryl containing bile acid analogs as FXR/TGR5 agonists and methods of use thereof
granted A61KA61K31/58A61P
Quick answer
US patent 10323061 (Heteroaryl containing bile acid analogs as FXR/TGR5 agonists and methods of use thereof) held by Enanta Pharmaceuticals, Inc. expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/58, A61P, A61P1/16